In line with recent observations on SMYD3 involvement in cancer development [28], no spontaneous liver tumor formation was detected in mice constitutively overexpressing SMYD3 in hepatocytes and no differences in tumor foci numbers were observed between wild-type and SMYD3-overexpressing mice after DEN treatment [11]. The gene discussed is SMYD3; the disease is cancer.